Azelis Group NV
Azelis Group NV (AZLGF) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for Azelis Group NV (AZLGF), featuring income statements, balance sheets, and cash flow data.
Azelis Group NV (AZLGF) Income Statement & Financial Overview
Review Azelis Group NV AZLGF income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| Revenue | $2.07B | $2.15B | $2.01B | $1.006B |
| Cost of Revenue | $1.80B | $1.63B | $1.76B | $777.44M |
| Gross Profit | $273.32M | $513.63M | $249.38M | $228.06M |
| Gross Profit Ratio | $0.13 | $0.24 | $0.12 | $0.23 |
| R&D Expenses | $0.00 | $0.00 | $717000.00 | $717000.00 |
| SG&A Expenses | $111.70M | $253.96M | $95.92M | $124.90M |
| Operating Expenses | $111.70M | $298.95M | $95.92M | $157.11M |
| Total Costs & Expenses | -$1.91B | $1.93B | $1.86B | $934.55M |
| Interest Income | $5.54M | $18.56M | $8.45M | $24.21M |
| Interest Expense | $71.48M | $135.81M | $70.70M | $0.00 |
| Depreciation & Amortization | $58.79M | $56.13M | $52.67M | $13.79M |
| EBITDA | $244.07M | $272.51M | $206.12M | $96.06M |
| EBITDA Ratio | $0.12 | $0.13 | $0.10 | $0.10 |
| Operating Income | $161.62M | $214.68M | $153.46M | $82.27M |
| Operating Income Ratio | $0.08 | $0.10 | $0.08 | $0.08 |
| Other Income/Expenses (Net) | -$47.82M | -$72.40M | -$106.72M | -$35.53M |
| Income Before Tax | $113.80M | $142.29M | $93.38M | $46.74M |
| Income Before Tax Ratio | $0.06 | $0.07 | $0.05 | $0.05 |
| Income Tax Expense | $24.48M | $42.16M | $13.35M | $6.67M |
| Net Income | $85.87M | $94.82M | $74.25M | $37.12M |
| Net Income Ratio | $0.04 | $0.04 | $0.04 | $0.04 |
| EPS | $0.35 | $0.39 | $0.30 | $0.15 |
| Diluted EPS | $0.35 | $0.39 | $0.30 | $0.15 |
| Weighted Avg Shares Outstanding | $243.77M | $243.56M | $243.77M | $244.31M |
| Weighted Avg Shares Outstanding (Diluted) | $244.02M | $243.56M | $246.08M | $244.22M |
Over the past four quarters, Azelis Group NV demonstrated steady revenue growth, increasing from $1.006B in Q3 2023 to $2.07B in Q4 2024. Operating income reached $161.62M in Q4 2024, maintaining a consistent 8% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $244.07M, reflecting operational efficiency. Net income dropped to $85.87M, with EPS at $0.35. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan